Edition:
United States

Profile: Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

3.05EUR
5:22am EST
Change (% chg)

€-0.02 (-0.65%)
Prev Close
€3.07
Open
€3.07
Day's High
€3.08
Day's Low
€3.05
Volume
32,820
Avg. Vol
565,821
52-wk High
€4.53
52-wk Low
€1.51

Mauna Kea Technologies SAS, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in the gastrointestinal and respiratory systems, primarily focusing on patients suffering from cancer. The main product offered by the Company is Cellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) which is a system providing physicians and researchers with high resolution cellular images of tissue in a real-time structure. The Company has marketing authorizations in Thailand, the United Kingdom, the USA, Brazil, Chile, South Korea, Poland, Russia and Saudi Arabia, among others.

Company Address

Mauna Kea Technologies SAS

9, rue d'Enghien, Paris 10
PARIS     75010
P: +331.48240345
F: +331.48241218

Company Web Links